Hammed, S. A., & Alwan, A. F. (2025). Metastatic EGFR-Mutant Lung Adenocarcinoma Patients: A Safety and Efficacy Analysis of First- and Third-Generation EGFR-TKIs. Middle Eastern Cancer and Oncology Journal, 1(4), 20–25. https://doi.org/10.61706/MECOJ160189